It is suggested that dysregulation of cuproptosis-associated hub genes is associated with cell-type-specific pathological alterations in PD, rather than demonstrating a direct causal or synergistic regulatory mechanism.
Abstract
Parkinson’s disease (PD) is a progressive neurodegenerative disorder whose pathogenesis involves complex interactions between metabolic dysfunction and neuroinflammation. The role of cuproptosis, a newly defined copper-dependent cell death pathway that is triggered during mitochondrial aerobic respiration, in PD remains incompletely understood. In this study, we employed integrated bioinformatics on bulk and single-cell RNA sequencing datasets to identify four hub cuproptosis-associated genes (DLD, ULK2, CCL8, and CCS) strongly linked to PD. Functional enrichment and immune infiltration analyses linked these genes to metabolic disturbances and altered immune landscapes in PD. Single-cell transcriptomics further revealed patterns of cell-type-specific expression of these genes and altered inferred intercellular communication, particularly through the NRG signaling pathway between microglia and astrocytes. Experimental validation in AAV9-A53T α-synuclein mouse models, utilizing cell-type-specific multiplex immunofluorescence (mIF) and western blot analysis, provided supportive evidence for reduced DLD levels in dopaminergic neurons, decreased ULK2 and CCL8 expression in microglia, and diminished CCS content in astrocytes, accompanied by increased FDX1 expression in these cell populations. These findings suggest that dysregulation of cuproptosis-associated hub genes is associated with cell-type-specific pathological alterations in PD, rather than demonstrating a direct causal or synergistic regulatory mechanism. Moreover, in silico drug–target interaction analysis identified four potential therapeutic compounds targeting these hub gene-related proteins. Our findings indicate a potential association between cuproptosis-associated gene dysregulation and metabolic–immune abnormalities in PD, providing candidate biomarkers and possible intervention targets for further validation.
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by prominent neuroinflammation. Microglia, the resident immune cells of the central nervous system, play a key role in AD-associated neuroinflammation, yet the molecular mechanisms regulating their inflammatory activation remain incomple...
Yao Yang, Cong-Hui Dai, Zong-Tang Xu et al.· Neurotherapeutics· 0 citations
KRT8 re‑expression reversed the protective effects of AKR1C2 knockdown, while KRT8 knockdown reversed AKR1C2 overexpression‑induced impairments, collectively confirming the causal role of the AKR1C2-KRT8 axis.
Jian-He Lin, Lian-Yu He, Jing-Ling Wang et al.· Brain Research Bulletin· 0 citations
This study establishes a novel AN-associated molecular patterns in PD, identifying DEK as a computationally identified neuron-specific factor associated with ac4C modification and neuroinflammatory cascades for PD patients.
Background: Polyendocrine metabolic ovarian syndrome (PMOS), previously known as polycystic ovary syndrome (PCOS), is a prevalent endocrine disorder increasingly associated with mild cognitive impairment (MCI). Mitochondrial dysfunction and immune dysregulation may underlie this association; however, shared molecular f...
Lu Wang, Zhi-Jing Tang, Hao Zhu et al.· Biomedicines· 0 citations
SLC7A11-associated astrocyte states are associated with redox imbalance and synaptic microenvironment remodeling in MS and provide a glial-state framework linking neuroinflammation, oxidative stress, and synaptic dysfunction, highlighting potential avenues for translational strategies in MS.
Jian Liu, Jun-Jun Yin, Meng Pu et al.· Journal of Translational Med...· 0 citations
A macrophage-centered anoikis-related immune signature in atherosclerosis is defined and HAVCR2 is identified, together with CD36, PLAU, TNF, PYCARD, SERPINA1, BLNK, and CHI3L1, as potential biomarkers and candidate targets for future diagnostic and therapeutic investigation.
Qiang Shen, Zheng-Feng Fan, Jin-Cheng Hou et al.· Frontiers in Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.